Long-term investing is all about owning high-quality businesses that can compound wealth over decades.
The best ASX 200 stocks to buy and hold forever are those with strong competitive advantages, resilient earnings, and the ability to adapt to changing market conditions.
If you're looking for three unstoppable stocks to anchor your portfolio after the market selloff, here are some of the best contenders that analysts rate as buys.
Image source: Getty Images
CSL Ltd (ASX: CSL)
CSL is a global leader in plasma therapies, vaccines, and biotech innovations.
With a history dating back over a century, this healthcare giant has continuously delivered strong earnings growth, driven by demand for its life-saving treatments.
What makes this ASX 200 stock a long-term winner is its massive research and development (R&D) investment. Each year the company reinvests around 11% of its sales back into R&D, ensuring it stays ahead of the competition. It also isn't afraid to make big acquisitions if it believes they will add value.
And while CSL's shares may seem expensive at times, long-term investors have been rewarded handsomely over the years.
Bell Potter is bullish on the company and has a buy rating and $335.00 price target on its shares.
Cochlear Ltd (ASX: COH)
Hearing loss is a growing global problem, and Cochlear is at the forefront of solving it. As the world's leading provider of cochlear implants, the ASX 200 stock benefits from an ageing population and rising healthcare accessibility.
Much like CSL, the company has invested heavily in R&D to build a significant competitive advantage. And with strong brand recognition, a high barrier to entry for competitors, and ongoing product innovation, the company is well-positioned to keep growing.
Citi currently has a buy rating and $300.00 price target on its shares.
Macquarie Group Ltd (ASX: MQG)
Macquarie has a well-earned reputation as one of the most innovative and resilient banks in the world. But unlike the big four banks, which rely on traditional lending, Macquarie generates much of its revenue from asset management, infrastructure, and investment banking.
This diversified business model has helped Macquarie outperform in various market conditions. Looking ahead, its strong presence in renewable energy and global infrastructure means it is well-placed for future growth. Long-term investors have enjoyed stellar returns from Macquarie, and there's little reason to believe this will change anytime soon.
Morgan Stanley believes this will be the case. The broker recently put an overweight rating and $253.00 price target on the ASX 200 stock.
